Pharmacist Medication Insights: Phesgo for HER2-Positive Breast Cancer
July 26th 2021The combination of pertuzumab, trastuzumab and hyaluronidase–zzxf is indicated for adult patients with HER2-positive breast cancer that has spread to other parts of the body and for adult patients with early HER2-positive breast cancer.
Expert: The Future of Products Containing Rare Cannabinoids is in Pharmacy
July 22nd 2021Pharmacy Times interviewed Dennis O’Neill, president and board member of BIOMEDICAN, on the outlook around the future of biosynthesis therapeutics that use rare cannabinoids to treat a range of health issues, from mental health disorders to diabetes.